Entry - #614563 - CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 13; CDCBM13 - OMIM
# 614563

CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 13; CDCBM13


Alternative titles; symbols

INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 13, FORMERLY; MRD13, FORMERLY
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13, FORMERLY
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13, WITH NEURONAL MIGRATION DEFECTS, FORMERLY


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
14q32.31 Cortical dysplasia, complex, with other brain malformations 13 614563 AD 3 DYNC1H1 600112
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
HEAD & NECK
Head
- Microcephaly (in some patients)
- Prominent forehead (in some patients)
Face
- Facial dysmorphism, mild (in some patients)
SKELETAL
Hands
- Small hands (in some patients)
Feet
- Foot deformities (in some patients)
NEUROLOGIC
Central Nervous System
- Global developmental delay
- Seizures, generalized
- Focal seizures
- Spastic tetraplegia (in some patients)
- Abnormal gait
- Malformations of cortical development
- Pachygyria, usually posterior
- Polymicrogyria, usually frontal (in some patients)
- Nodular heterotopia (in some patients)
- Thin corpus callosum (in some patients)
- Dysmorphic basal ganglia (in some patients)
- Cerebellar hypoplasia (in some patients)
- Brainstem hypoplasia (in some patients)
Peripheral Nervous System
- Axonal neuropathy (in some patients)
- Hyporeflexia (in some patients)
Behavioral Psychiatric Manifestations
- Autistic features (in some patients)
MISCELLANEOUS
- Most patients have de novo mutations
- Dysmorphic features are mild or variable
MOLECULAR BASIS
- Caused by mutation in the dynein, cytoplasmic 1, heavy chain 1 gene (DYNC1H1, 600112.0002)
Cortical dysplasia, complex, with other brain malformations - PS614039 - 15 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
2p12 Cortical dysplasia, complex, with other brain malformations 9 AR 3 618174 CTNNA2 114025
2q23.1-q23.2 Cortical dysplasia, complex, with other brain malformations 2 AD 3 615282 KIF5C 604593
5q12.1 Cortical dysplasia, complex, with other brain malformations 3 AD 3 615411 KIF2A 602591
6p25.2 Cortical dysplasia, complex, with other brain malformations 5 AD 3 615763 TUBB2A 615101
6p25.2 Cortical dysplasia, complex, with other brain malformations 7 AD 3 610031 TUBB2B 612850
6p21.33 Cortical dysplasia, complex, with other brain malformations 6 AD 3 615771 TUBB 191130
9q34.3 Cortical dysplasia, complex, with other brain malformations 12 AR 3 620316 CAMSAP1 613774
10q26.3 Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures AR 3 618737 TUBGCP2 617817
14q32.31 Cortical dysplasia, complex, with other brain malformations 13 AD 3 614563 DYNC1H1 600112
14q32.33 Cortical dysplasia, complex, with other brain malformations 11 AR 3 620156 KIF26A 613231
16q21 Cortical dysplasia, complex, with other brain malformations 14A, (bilateral frontoparietal) AR 3 606854 ADGRG1 604110
16q21 Cortical dysplasia, complex, with other brain malformations 14B, (bilateral perisylvian) 3 615752 ADGRG1 604110
16q24.3 Cortical dysplasia, complex, with other brain malformations 1 AD 3 614039 TUBB3 602661
17q21.2 Cortical dysplasia, complex, with other brain malformations 4 AD 3 615412 TUBG1 191135
19p13.3 Cortical dysplasia, complex, with other brain malformations 10 AR 3 618677 APC2 612034

TEXT

A number sign (#) is used with this entry because of evidence that complex cortical dysplasia with other brain malformations-13 (CDCBM13) is caused by heterozygous mutation in the DYNC1H1 gene (600112) on chromosome 14q32.


Description

Complex cortical dysplasia with other brain malformations-13 (CDCBM13) is an autosomal dominant neurodevelopmental disorder characterized by global developmental delay with impaired intellectual development. Brain imaging shows variable neuronal migration defects resulting in cortical malformations, including pachygyria. More variable features include early-onset seizures and dysmorphic features. Some patients may also show signs of peripheral neuropathy, such as abnormal gait, hyporeflexia, and foot deformities (summary by Willemsen et al., 2012 and Poirier et al., 2013).

For a discussion of genetic heterogeneity of CDCBM, see CDCBM1 (614039).


Clinical Features

Vissers et al. (2010) reported a 4-year-old boy with global developmental delay. He showed hypotonia at age 6 months, followed by delayed psychomotor development. Mild dysmorphic features included prominent forehead, plagiocephaly, hypotonic face with downslanting palpebral fissures, and short, broad hands and feet. Brain MRI was reported as normal. His parents were unaffected. Follow-up of the patient at age 6 years by Willemsen et al. (2012) noted that he had hypotonia, hyporeflexia, and broad-based waddling gait with toe walking. Reevaluation of brain MRI showed signs of bilateral cortical malformation with deficient gyration of the frontal lobes and an area suggestive of focal cortical dysplasia. Willemsen et al. (2012) also reported a 51-year-old woman with severe mental retardation and an inability to walk or speak. She had short stature, microcephaly, clubfeet, and small hands and feet with short toes. Craniofacial features included brachycephaly, prominent forehead, hypertelorism, deep-set eyes, wide mouth with everted lower lip, and downturned corners of the mouth. She developed generalized seizures at age 3 years. Other features included kyphoscoliosis, spastic tetraplegia, and swallowing difficulties. Cerebral CT scan at the age 46 years showed enlarged ventricles and clear signs of cortical malformation with wide opercular regions and an abnormal flat cortex with only a few simple and shallow sulci; MRI scan was not possible.

Poirier et al. (2013) reported 8 unrelated patients with moderate to severely impaired intellectual development associated with cortical brain malformations on MRI. All but 1 had seizures, most of early onset. Three had microcephaly, 3 were bedridden with spastic tetraplegia, 2 were described as having 'awkwardness' on neurologic examination, and 3 patients had foot deformities consistent with axonal neuropathy. Brain MRI showed predominantly posterior pachygyria, and some patients also had frontal polymicrogyria or nodular heterotopia. Several patients also had other brain abnormalities, including dysmorphic basal ganglia and hypoplasia of the corpus callosum, brainstem, and/or cerebellum.


Inheritance

The majority of reported patients with CDCBM13 had de novo mutations in the DYNC1H1 gene, consistent with sporadic occurrence of the disorder. One family with a mild phenotype showed autosomal dominant inheritance (Poirier et al., 2013).


Molecular Genetics

By family-based exome sequencing of 10 case-parent trios with global developmental delay, Vissers et al. (2010) identified a de novo heterozygous mutation in the DYNC1H1 gene (H3822P; 600112.0002) in 1 patient. Willemsen et al. (2012) identified a second de novo heterozygous mutation in the DYNC1H1 gene (E1518K; 600112.0003) in a 51-year-old woman with severe intellectual disability since infancy and an inability to walk or speak. Willemsen et al. (2012) noted that DYNC1H1 interacts with LIS1 (601545), haploinsufficiency of which results in the severe neuronal migration disorder lissencephaly-1 (607432), and that Dync1h1 mutant mice show neuronal migration defects (Ori-McKenney and Vallee, 2011), providing evidence of the pathogenicity of the mutations. Willemsen et al. (2012) also noted that their 2 patients showed variable signs consistent with peripheral neuropathy and that some patients with CMT2O (614228) (Weedon et al., 2011) carrying a DYNC1H1 mutation showed learning difficulties, indicating that DYNC1H1 mutations may result in a broad neurologic phenotypic spectrum.

Poirier et al. (2013) identified 8 different de novo heterozygous mutations in the DYNC1H1 gene (see, e.g., 600112.0007-600112.0009) in 8 unrelated patients ascertained for evaluation due to malformations of cortical development. Mutations in the first several patients were found by whole-exome sequencing, whereas subsequent patients were identified by direct sequencing of this gene in a larger cohort of affected individuals. In vitro functional expression studies of 2 of the variants showed that the mutant proteins had decreased microtubule binding affinity compared to wildtype. In addition, there was 1 family in which a mother and her 2 children carried a missense variant (K3241T): 1 of the children had mild intellectual disability, but the mother and the other child had normal cognition. All 3 were normocephalic, showed posterior pachygyria, and had focal seizures. No functional studies were performed on the K3241T variant, which occurred at a nonconserved residue.

Jamuar et al. (2014) used a customized panel of known and candidate genes associated with brain malformations to apply targeted high-coverage sequencing (depth greater than or equal to 200x) to leukocyte-derived DNA samples from 158 individuals with brain malformations. They found potentially causal mutations in the candidate gene DYNC1H1 in 2 individuals with pachygyria; in a parallel study they had found de novo mutations in DYNC1H1 in 2 other individuals with pachygyria. The 4 individuals had strikingly similar MRI findings, with posterior-predominant pachygyria, thickened cortex in the perisylvian region, and mildly dysmorphic corpus callosum. One of the individuals identified in the report of Jamuar et al. (2014) had onset of seizures at age 5 years and mental and motor retardation. The other had dysarthria and cognitive delay but normal vision, hearing, and head circumference, and no seizures.


REFERENCES

  1. Jamuar, S. S., Lam, A. N., Kircher, M., D'Gama, A. M., Wang, J., Barry, B. J., Zhang, X., Hill, R. S., Partlow, J. N., Rozzo, A., Servattalab, S., Mehta, B. K., and 20 others. Somatic mutations in cerebral cortical malformations. New Eng. J. Med. 371: 733-743, 2014. [PubMed: 25140959, images, related citations] [Full Text]

  2. Ori-McKenney, K. M., Vallee, R. B. Neuronal migration defects in the Loa dynein mutant mouse. Neural Dev. 6: 26, 2011. Note: Electronic Article. [PubMed: 21612657, images, related citations] [Full Text]

  3. Poirier, K., Lebrun, N., Broix, L., Tian, G., Saillour, Y., Boscheron, C., Parrini, E., Valence, S., Saint Pierre, B., Oger, M., Lacombe, D., Genevieve, D., and 23 others. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nature Genet. 45: 639-647, 2013. Note: Erratum: Nature Genet. 45: 962 only, 2013. [PubMed: 23603762, images, related citations] [Full Text]

  4. Vissers, L. E. L. M., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van Lier, B., Arts, P., Wieskamp, N., del Rosario, M., van Bon, B. W. M., Hoischen, A., de Vries, B. B. A., Brunner, H. G., Veltman, J. A. A de novo paradigm for mental retardation. Nature Genet. 42: 1109-1112, 2010. [PubMed: 21076407, related citations] [Full Text]

  5. Weedon, M. N., Hastings, R., Caswell, R., Xie, W., Paszkiewicz, K., Antoniadi, T., Williams, M., King, C., Greenhalgh, L., Newbury-Ecob, R., Ellard, S. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 89: 308-312, 2011. [PubMed: 21820100, images, related citations] [Full Text]

  6. Willemsen, M. H., Vissers, L. E. L., Willemsen, M. A. A. P., van Bon, B. W. M., Kroes, T., de Ligt, J., de Vries, B. B., Schoots, J., Lugtenberg, D., Hamel, B. C. J., van Bokhoven, H., Brunner, H. G., Veltman, J. A., Kleefstra, T. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J. Med. Genet. 49: 179-183, 2012. [PubMed: 22368300, related citations] [Full Text]


Ada Hamosh - updated : 9/2/2014
Cassandra L. Kniffin - updated : 6/27/2013
Creation Date:
Cassandra L. Kniffin : 4/9/2012
carol : 04/10/2023
alopez : 04/07/2023
ckniffin : 04/07/2023
alopez : 04/01/2022
carol : 12/06/2017
carol : 11/06/2014
alopez : 9/2/2014
carol : 8/28/2013
carol : 7/9/2013
ckniffin : 6/27/2013
terry : 5/8/2012
alopez : 4/10/2012
alopez : 4/10/2012
terry : 4/10/2012
terry : 4/10/2012
ckniffin : 4/9/2012

# 614563

CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 13; CDCBM13


Alternative titles; symbols

INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 13, FORMERLY; MRD13, FORMERLY
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13, FORMERLY
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13, WITH NEURONAL MIGRATION DEFECTS, FORMERLY


ORPHA: 178469;   DO: 0070043;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
14q32.31 Cortical dysplasia, complex, with other brain malformations 13 614563 Autosomal dominant 3 DYNC1H1 600112

TEXT

A number sign (#) is used with this entry because of evidence that complex cortical dysplasia with other brain malformations-13 (CDCBM13) is caused by heterozygous mutation in the DYNC1H1 gene (600112) on chromosome 14q32.


Description

Complex cortical dysplasia with other brain malformations-13 (CDCBM13) is an autosomal dominant neurodevelopmental disorder characterized by global developmental delay with impaired intellectual development. Brain imaging shows variable neuronal migration defects resulting in cortical malformations, including pachygyria. More variable features include early-onset seizures and dysmorphic features. Some patients may also show signs of peripheral neuropathy, such as abnormal gait, hyporeflexia, and foot deformities (summary by Willemsen et al., 2012 and Poirier et al., 2013).

For a discussion of genetic heterogeneity of CDCBM, see CDCBM1 (614039).


Clinical Features

Vissers et al. (2010) reported a 4-year-old boy with global developmental delay. He showed hypotonia at age 6 months, followed by delayed psychomotor development. Mild dysmorphic features included prominent forehead, plagiocephaly, hypotonic face with downslanting palpebral fissures, and short, broad hands and feet. Brain MRI was reported as normal. His parents were unaffected. Follow-up of the patient at age 6 years by Willemsen et al. (2012) noted that he had hypotonia, hyporeflexia, and broad-based waddling gait with toe walking. Reevaluation of brain MRI showed signs of bilateral cortical malformation with deficient gyration of the frontal lobes and an area suggestive of focal cortical dysplasia. Willemsen et al. (2012) also reported a 51-year-old woman with severe mental retardation and an inability to walk or speak. She had short stature, microcephaly, clubfeet, and small hands and feet with short toes. Craniofacial features included brachycephaly, prominent forehead, hypertelorism, deep-set eyes, wide mouth with everted lower lip, and downturned corners of the mouth. She developed generalized seizures at age 3 years. Other features included kyphoscoliosis, spastic tetraplegia, and swallowing difficulties. Cerebral CT scan at the age 46 years showed enlarged ventricles and clear signs of cortical malformation with wide opercular regions and an abnormal flat cortex with only a few simple and shallow sulci; MRI scan was not possible.

Poirier et al. (2013) reported 8 unrelated patients with moderate to severely impaired intellectual development associated with cortical brain malformations on MRI. All but 1 had seizures, most of early onset. Three had microcephaly, 3 were bedridden with spastic tetraplegia, 2 were described as having 'awkwardness' on neurologic examination, and 3 patients had foot deformities consistent with axonal neuropathy. Brain MRI showed predominantly posterior pachygyria, and some patients also had frontal polymicrogyria or nodular heterotopia. Several patients also had other brain abnormalities, including dysmorphic basal ganglia and hypoplasia of the corpus callosum, brainstem, and/or cerebellum.


Inheritance

The majority of reported patients with CDCBM13 had de novo mutations in the DYNC1H1 gene, consistent with sporadic occurrence of the disorder. One family with a mild phenotype showed autosomal dominant inheritance (Poirier et al., 2013).


Molecular Genetics

By family-based exome sequencing of 10 case-parent trios with global developmental delay, Vissers et al. (2010) identified a de novo heterozygous mutation in the DYNC1H1 gene (H3822P; 600112.0002) in 1 patient. Willemsen et al. (2012) identified a second de novo heterozygous mutation in the DYNC1H1 gene (E1518K; 600112.0003) in a 51-year-old woman with severe intellectual disability since infancy and an inability to walk or speak. Willemsen et al. (2012) noted that DYNC1H1 interacts with LIS1 (601545), haploinsufficiency of which results in the severe neuronal migration disorder lissencephaly-1 (607432), and that Dync1h1 mutant mice show neuronal migration defects (Ori-McKenney and Vallee, 2011), providing evidence of the pathogenicity of the mutations. Willemsen et al. (2012) also noted that their 2 patients showed variable signs consistent with peripheral neuropathy and that some patients with CMT2O (614228) (Weedon et al., 2011) carrying a DYNC1H1 mutation showed learning difficulties, indicating that DYNC1H1 mutations may result in a broad neurologic phenotypic spectrum.

Poirier et al. (2013) identified 8 different de novo heterozygous mutations in the DYNC1H1 gene (see, e.g., 600112.0007-600112.0009) in 8 unrelated patients ascertained for evaluation due to malformations of cortical development. Mutations in the first several patients were found by whole-exome sequencing, whereas subsequent patients were identified by direct sequencing of this gene in a larger cohort of affected individuals. In vitro functional expression studies of 2 of the variants showed that the mutant proteins had decreased microtubule binding affinity compared to wildtype. In addition, there was 1 family in which a mother and her 2 children carried a missense variant (K3241T): 1 of the children had mild intellectual disability, but the mother and the other child had normal cognition. All 3 were normocephalic, showed posterior pachygyria, and had focal seizures. No functional studies were performed on the K3241T variant, which occurred at a nonconserved residue.

Jamuar et al. (2014) used a customized panel of known and candidate genes associated with brain malformations to apply targeted high-coverage sequencing (depth greater than or equal to 200x) to leukocyte-derived DNA samples from 158 individuals with brain malformations. They found potentially causal mutations in the candidate gene DYNC1H1 in 2 individuals with pachygyria; in a parallel study they had found de novo mutations in DYNC1H1 in 2 other individuals with pachygyria. The 4 individuals had strikingly similar MRI findings, with posterior-predominant pachygyria, thickened cortex in the perisylvian region, and mildly dysmorphic corpus callosum. One of the individuals identified in the report of Jamuar et al. (2014) had onset of seizures at age 5 years and mental and motor retardation. The other had dysarthria and cognitive delay but normal vision, hearing, and head circumference, and no seizures.


REFERENCES

  1. Jamuar, S. S., Lam, A. N., Kircher, M., D'Gama, A. M., Wang, J., Barry, B. J., Zhang, X., Hill, R. S., Partlow, J. N., Rozzo, A., Servattalab, S., Mehta, B. K., and 20 others. Somatic mutations in cerebral cortical malformations. New Eng. J. Med. 371: 733-743, 2014. [PubMed: 25140959] [Full Text: https://doi.org/10.1056/NEJMoa1314432]

  2. Ori-McKenney, K. M., Vallee, R. B. Neuronal migration defects in the Loa dynein mutant mouse. Neural Dev. 6: 26, 2011. Note: Electronic Article. [PubMed: 21612657] [Full Text: https://doi.org/10.1186/1749-8104-6-26]

  3. Poirier, K., Lebrun, N., Broix, L., Tian, G., Saillour, Y., Boscheron, C., Parrini, E., Valence, S., Saint Pierre, B., Oger, M., Lacombe, D., Genevieve, D., and 23 others. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nature Genet. 45: 639-647, 2013. Note: Erratum: Nature Genet. 45: 962 only, 2013. [PubMed: 23603762] [Full Text: https://doi.org/10.1038/ng.2613]

  4. Vissers, L. E. L. M., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van Lier, B., Arts, P., Wieskamp, N., del Rosario, M., van Bon, B. W. M., Hoischen, A., de Vries, B. B. A., Brunner, H. G., Veltman, J. A. A de novo paradigm for mental retardation. Nature Genet. 42: 1109-1112, 2010. [PubMed: 21076407] [Full Text: https://doi.org/10.1038/ng.712]

  5. Weedon, M. N., Hastings, R., Caswell, R., Xie, W., Paszkiewicz, K., Antoniadi, T., Williams, M., King, C., Greenhalgh, L., Newbury-Ecob, R., Ellard, S. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 89: 308-312, 2011. [PubMed: 21820100] [Full Text: https://doi.org/10.1016/j.ajhg.2011.07.002]

  6. Willemsen, M. H., Vissers, L. E. L., Willemsen, M. A. A. P., van Bon, B. W. M., Kroes, T., de Ligt, J., de Vries, B. B., Schoots, J., Lugtenberg, D., Hamel, B. C. J., van Bokhoven, H., Brunner, H. G., Veltman, J. A., Kleefstra, T. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J. Med. Genet. 49: 179-183, 2012. [PubMed: 22368300] [Full Text: https://doi.org/10.1136/jmedgenet-2011-100542]


Contributors:
Ada Hamosh - updated : 9/2/2014
Cassandra L. Kniffin - updated : 6/27/2013

Creation Date:
Cassandra L. Kniffin : 4/9/2012

Edit History:
carol : 04/10/2023
alopez : 04/07/2023
ckniffin : 04/07/2023
alopez : 04/01/2022
carol : 12/06/2017
carol : 11/06/2014
alopez : 9/2/2014
carol : 8/28/2013
carol : 7/9/2013
ckniffin : 6/27/2013
terry : 5/8/2012
alopez : 4/10/2012
alopez : 4/10/2012
terry : 4/10/2012
terry : 4/10/2012
ckniffin : 4/9/2012